← Back to Search

Behavioural Intervention

Virtual Cardiology Program for Heart Failure (ELEVATE-HF Trial)

N/A
Recruiting
Led By Adam DeVore
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥18 years of age
Be older than 18 years old
Must not have
History of prior heart transplant or currently listed for heart transplant
Chronic use of intravenous inotropic medications including milrinone, dobutamine, or dopamine
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 day, 60 day, 120 day
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if a virtual cardiology program that educates patients on heart failure, monitors their condition, and adjusts medications quickly is better than the usual care for patients recently hospitalized with heart failure

Who is the study for?
This trial is for patients recently hospitalized with acute decompensated heart failure. It's designed to help those who could benefit from a virtual cardiology program that educates and monitors them, adjusting their medications as needed.
What is being tested?
The study tests the safety and effectiveness of a remote virtual cardiology program against standard care. The program provides education, monitors symptoms, and adjusts heart failure medications remotely.
What are the potential side effects?
Since this trial involves educational and monitoring components rather than drugs or invasive procedures, side effects are minimal but may include privacy concerns or stress related to technology use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a heart transplant or am on the waiting list for one.
Select...
I regularly use IV medications like milrinone, dobutamine, or dopamine.
Select...
My kidney function is very low or I am on long-term dialysis.
Select...
I am currently in hospice care.
Select...
My doctor does not expect me to live more than a year due to an illness other than heart failure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 day, 60 day, 120 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 day, 60 day, 120 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in the number of classes of HF (heart failure) medications
Number of participants with combined Emergency department visits and hospitalizations
Other study objectives
Change in Kansas City Cardiomyopathy Questionnaire Overall Summary score
Change in participant-reported medication adherence using the Voils score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Remote Virtual Cardiology ProgramExperimental Treatment1 Intervention
The Ventricle Health program will remotely receive daily vital signs directly from a blood pressure cuff and scale provided to the participant. In addition, the program will also remotely receive oxygen levels and electrical heart activity directly from a Pulse Ox and an EKG Single-Lead monitor, provided to the participant. All of this data will be transmitted to the Ventricle Health program. The Ventricle Health team, consisting of Cardiologists and clinical staff, will use this data to titrate medications and make clinical decisions.
Group II: Usual CareActive Control1 Intervention
Routine clinical care will be followed. Participants should be recommended for the best possible outpatient heart failure care at each site.

Find a Location

Who is running the clinical trial?

Ventricle HealthUNKNOWN
Duke UniversityLead Sponsor
2,446 Previous Clinical Trials
3,067,649 Total Patients Enrolled
64 Trials studying Heart Failure
46,519 Patients Enrolled for Heart Failure
Adam DeVorePrincipal InvestigatorDuke University
~120 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top